Inpatient Financial Burden of Atopic Dermatitis in the United States

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Inpatient Financial Burden of Atopic Dermatitis in the United States. / Narla, Shanthi; Hsu, Derek Y; Thyssen, Jacob P; Silverberg, Jonathan I.

In: The Journal of Investigative Dermatology, Vol. 137, No. 7, 2017, p. 1461-1467.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Narla, S, Hsu, DY, Thyssen, JP & Silverberg, JI 2017, 'Inpatient Financial Burden of Atopic Dermatitis in the United States', The Journal of Investigative Dermatology, vol. 137, no. 7, pp. 1461-1467. https://doi.org/10.1016/j.jid.2017.02.975

APA

Narla, S., Hsu, D. Y., Thyssen, J. P., & Silverberg, J. I. (2017). Inpatient Financial Burden of Atopic Dermatitis in the United States. The Journal of Investigative Dermatology, 137(7), 1461-1467. https://doi.org/10.1016/j.jid.2017.02.975

Vancouver

Narla S, Hsu DY, Thyssen JP, Silverberg JI. Inpatient Financial Burden of Atopic Dermatitis in the United States. The Journal of Investigative Dermatology. 2017;137(7):1461-1467. https://doi.org/10.1016/j.jid.2017.02.975

Author

Narla, Shanthi ; Hsu, Derek Y ; Thyssen, Jacob P ; Silverberg, Jonathan I. / Inpatient Financial Burden of Atopic Dermatitis in the United States. In: The Journal of Investigative Dermatology. 2017 ; Vol. 137, No. 7. pp. 1461-1467.

Bibtex

@article{c9f66e94a66c47e8bed9f0d158e36545,
title = "Inpatient Financial Burden of Atopic Dermatitis in the United States",
abstract = "Little is known about the inpatient burden of atopic dermatitis (AD). We sought to determine the risk factors and financial burden of hospitalizations for AD in the United States. Data were analyzed from the 2002-2012 National Inpatient Sample, including a 20{\%} representative sample of all hospitalizations in the United States. Hospitalization rates for AD or eczema were highest in the northeast during the winter and south during the summer. Geometric mean cost of care (95{\%} confidence interval) was lower for a primary diagnosis of AD or eczema versus no AD or eczema in adults ($3,502 [$3,360-$3,651] vs. $6,849 [$6,775-$6,925]; P = 0.0004) and children ($2,716 [$2,542-$2,903] vs. $4,488 [$4,302-$4,682]; P = 0.0004). However, the high prevalence of hospitalization resulted in total inpatient costs of $8,288,083 per year for adults and $3,333,868 per year for children. In conclusion, there is a substantial inpatient financial burden of AD in the United States.",
keywords = "Adolescent, Adult, Child, Cost of Illness, Costs and Cost Analysis, Dermatitis, Atopic/economics, Female, Health Care Costs, Hospitalization/economics, Humans, Inpatients, Male, Prevalence, Retrospective Studies, United States/epidemiology, Young Adult",
author = "Shanthi Narla and Hsu, {Derek Y} and Thyssen, {Jacob P} and Silverberg, {Jonathan I}",
note = "Copyright {\circledC} 2017 The Authors. Published by Elsevier Inc. All rights reserved.",
year = "2017",
doi = "10.1016/j.jid.2017.02.975",
language = "English",
volume = "137",
pages = "1461--1467",
journal = "Journal of Investigative Dermatology",
issn = "0022-202X",
publisher = "nature publishing group",
number = "7",

}

RIS

TY - JOUR

T1 - Inpatient Financial Burden of Atopic Dermatitis in the United States

AU - Narla, Shanthi

AU - Hsu, Derek Y

AU - Thyssen, Jacob P

AU - Silverberg, Jonathan I

N1 - Copyright © 2017 The Authors. Published by Elsevier Inc. All rights reserved.

PY - 2017

Y1 - 2017

N2 - Little is known about the inpatient burden of atopic dermatitis (AD). We sought to determine the risk factors and financial burden of hospitalizations for AD in the United States. Data were analyzed from the 2002-2012 National Inpatient Sample, including a 20% representative sample of all hospitalizations in the United States. Hospitalization rates for AD or eczema were highest in the northeast during the winter and south during the summer. Geometric mean cost of care (95% confidence interval) was lower for a primary diagnosis of AD or eczema versus no AD or eczema in adults ($3,502 [$3,360-$3,651] vs. $6,849 [$6,775-$6,925]; P = 0.0004) and children ($2,716 [$2,542-$2,903] vs. $4,488 [$4,302-$4,682]; P = 0.0004). However, the high prevalence of hospitalization resulted in total inpatient costs of $8,288,083 per year for adults and $3,333,868 per year for children. In conclusion, there is a substantial inpatient financial burden of AD in the United States.

AB - Little is known about the inpatient burden of atopic dermatitis (AD). We sought to determine the risk factors and financial burden of hospitalizations for AD in the United States. Data were analyzed from the 2002-2012 National Inpatient Sample, including a 20% representative sample of all hospitalizations in the United States. Hospitalization rates for AD or eczema were highest in the northeast during the winter and south during the summer. Geometric mean cost of care (95% confidence interval) was lower for a primary diagnosis of AD or eczema versus no AD or eczema in adults ($3,502 [$3,360-$3,651] vs. $6,849 [$6,775-$6,925]; P = 0.0004) and children ($2,716 [$2,542-$2,903] vs. $4,488 [$4,302-$4,682]; P = 0.0004). However, the high prevalence of hospitalization resulted in total inpatient costs of $8,288,083 per year for adults and $3,333,868 per year for children. In conclusion, there is a substantial inpatient financial burden of AD in the United States.

KW - Adolescent

KW - Adult

KW - Child

KW - Cost of Illness

KW - Costs and Cost Analysis

KW - Dermatitis, Atopic/economics

KW - Female

KW - Health Care Costs

KW - Hospitalization/economics

KW - Humans

KW - Inpatients

KW - Male

KW - Prevalence

KW - Retrospective Studies

KW - United States/epidemiology

KW - Young Adult

U2 - 10.1016/j.jid.2017.02.975

DO - 10.1016/j.jid.2017.02.975

M3 - Journal article

C2 - 28259687

VL - 137

SP - 1461

EP - 1467

JO - Journal of Investigative Dermatology

JF - Journal of Investigative Dermatology

SN - 0022-202X

IS - 7

ER -

ID: 196884371